Jackie Han

705 total citations
28 papers, 477 citations indexed

About

Jackie Han is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jackie Han has authored 28 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 6 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jackie Han's work include Lipoproteins and Cardiovascular Health (7 papers), Renal cell carcinoma treatment (6 papers) and Renal and related cancers (5 papers). Jackie Han is often cited by papers focused on Lipoproteins and Cardiovascular Health (7 papers), Renal cell carcinoma treatment (6 papers) and Renal and related cancers (5 papers). Jackie Han collaborates with scholars based in United States, United Kingdom and Switzerland. Jackie Han's co-authors include Daniel Promislow, Davina Derous, John R. Speakman, Luonan Chen, David Lusseau, Alex Douglas, Sharon E. Mitchell, Yingchun Wang, Cara L. Green and Mohsen Saleh Elalfy and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jackie Han

28 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jackie Han United States	12	175	129	80	75	72	28	477
Kevin Funk United States	11	256 1.5×	195 1.5×	37 0.5×	92 1.2×	41 0.6×	21	699
Julia Huei‐Mei Chang Taiwan	12	88 0.5×	167 1.3×	39 0.5×	21 0.3×	7 0.1×	26	532
Conny van Oostrom Netherlands	9	92 0.5×	311 2.4×	63 0.8×	19 0.3×	33 0.5×	13	512
Talat Afroze Canada	12	71 0.4×	261 2.0×	13 0.2×	63 0.8×	18 0.3×	20	512
Marco Guevara‐Aguirre United States	8	238 1.4×	296 2.3×	104 1.3×	69 0.9×	6 0.1×	10	743
Meng Teng Peh Singapore	8	127 0.7×	209 1.6×	26 0.3×	48 0.6×	6 0.1×	9	611
Ashok Mandala United States	11	67 0.4×	126 1.0×	8 0.1×	26 0.3×	25 0.3×	16	362
Carly Cederquist United States	9	290 1.7×	404 3.1×	16 0.2×	58 0.8×	8 0.1×	13	618
Jacqueline A. Brinkman United States	10	163 0.9×	190 1.5×	80 1.0×	45 0.6×	3 0.0×	13	443
Elizabeth K. Fletcher United States	11	54 0.3×	121 0.9×	4 0.1×	139 1.9×	51 0.7×	15	452

Countries citing papers authored by Jackie Han

Since Specialization

Citations

This map shows the geographic impact of Jackie Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jackie Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jackie Han more than expected).

Fields of papers citing papers by Jackie Han

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jackie Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jackie Han. The network helps show where Jackie Han may publish in the future.

Co-authorship network of co-authors of Jackie Han

This figure shows the co-authorship network connecting the top 25 collaborators of Jackie Han. A scholar is included among the top collaborators of Jackie Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jackie Han. Jackie Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Landmesser, Ulf, Wolfgang Köenig, Lawrence A. Leiter, et al.. (2025). Efficacy and safety of inclisiran based on background lipid-lowering treatment. European Journal of Preventive Cardiology. 2 indexed citations

Leiter, Lawrence A., Frederick J. Raal, Gregory G. Schwartz, et al.. (2024). Inclisiran in individuals with diabetes or obesity: Post hoc pooled analyses of the ORION ‐9, ORION ‐10 and ORION ‐11 Phase 3 randomized trials. Diabetes Obesity and Metabolism. 26(8). 3223–3237. 13 indexed citations

Wright, R. Scott, Kausik K. Ray, Ulf Landmesser, et al.. (2024). Effects of Inclisiran in Patients With Atherosclerotic Cardiovascular Disease. Mayo Clinic Proceedings. 99(8). 1222–1235. 7 indexed citations

Köenig, Wolfgang, Kausik K. Ray, Ulf Landmesser, et al.. (2023). Efficacy and safety of inclisiran in patients with cerebrovascular disease: ORION-9, ORION-10, and ORION-11. SHILAP Revista de lepidopterología. 14. 100503–100503. 11 indexed citations

Landmesser, Ulf, Wolfgang Köenig, Lawrence A. Leiter, et al.. (2023). Inclisiran in patients with prior myocardial infarction: A post hoc pooled analysis of the ORION-10 and ORION-11 Phase 3 randomised trials. Atherosclerosis. 386. 117354–117354. 7 indexed citations

Köenig, Wolfgang, Lorena Garcia Conde, Ulf Landmesser, et al.. (2022). Efficacy and Safety of Inclisiran in Patients with Polyvascular Disease: Pooled, Post Hoc Analysis of the ORION-9, ORION-10, and ORION-11 Phase 3 Randomized Controlled Trials. Cardiovascular Drugs and Therapy. 38(3). 493–503. 23 indexed citations

Lee, Stephanie J., Franco Locatelli, Francis Ayuk, et al.. (2021). Patient-Reported Outcomes (PROs) Among Patients With Steroid-Refractory or -Dependent Chronic Graft-vs-Host Disease (cGVHD) Randomized to Ruxolitinib (RUX) vs Best Available Therapy (BAT). Blood. 138(Supplement 1). 3909–3909. 1 indexed citations

Liu, Fei, Sharon E. Mitchell, Huanfei Ma, et al.. (2020). The Effects of Graded Levels of Calorie Restriction XV: Phase Space Attractors Reveal Distinct Behavioral Phenotypes. The Journals of Gerontology Series A. 75(5). 858–866. 3 indexed citations

Sternberg, Cora N., Robert J. Motzer, Thomas E. Hutson, et al.. (2019). COMPARZ Post Hoc Analysis: Characterizing Pazopanib Responders With Advanced Renal Cell Carcinoma. Clinical Genitourinary Cancer. 17(6). 425–435.e4. 13 indexed citations

10.

Matthews, David R., Päivi M. Paldánius, Michael Stümvoll, et al.. (2019). A pre‐specified statistical analysis plan for the VERIFY study: Vildagliptin efficacy in combination with metformin for early treatment of T2DM. Diabetes Obesity and Metabolism. 21(10). 2240–2247. 7 indexed citations

11.

Guo, Jun, Jie Jin, Mototsugu Oya, et al.. (2018). Safety of pazopanib and sunitinib in treatment-naive patients with metastatic renal cell carcinoma: Asian versus non-Asian subgroup analysis of the COMPARZ trial. Journal of Hematology & Oncology. 11(1). 69–69. 33 indexed citations

12.

Souza, Paul L. de, Shirley Wong, Sanjeev Sewak, et al.. (2018). Phase II study of sequential first-line pazopanib (PAZ) followed by everolimus (EVE) in patients (pts) with advanced or metastatic renal cell carcinoma (RCC) (CATChEz Study).. Journal of Clinical Oncology. 36(6_suppl). 648–648. 1 indexed citations

13.

Mitchell, Sharon E., Davina Derous, Cara L. Green, et al.. (2017). The effects of graded levels of calorie restriction: VIII. Impact of short term calorie and protein restriction on basal metabolic rate in the C57BL/6 mouse. Oncotarget. 8(11). 17453–17474. 33 indexed citations

14.

Bjarnason, Georg A., Christian Kollmannsberger, Qasim Ahmad, et al.. (2017). Effects of pazopanib (PAZ) and sunitinib (SUN) dose modification on safety and efficacy in patients with metastatic renal cell carcinoma (mRCC) from COMPARZ.. Journal of Clinical Oncology. 35(15_suppl). 4574–4574. 6 indexed citations

15.

Jia, Yuanhui, Pishun Li, Fang Lan, et al.. (2016). Negative regulation of DNMT3A de novo DNA methylation by frequently overexpressed UHRF family proteins as a mechanism for widespread DNA hypomethylation in cancer. Cell Discovery. 2(1). 16007–16007. 64 indexed citations

16.

Pennell, Dudley J., John B. Porter, Antonio Piga, et al.. (2015). Association of Liver Iron Concentration Levels with Myocardial T2* Responses in Transfusion-Dependent Thalassemia Major Patients Treated with Deferasirox and Deferoxamine- Extension of Cordelia Study. Blood. 126(23). 2155–2155. 1 indexed citations

17.

Mitchell, Sharon E., Jane L. Hurst, Davina Derous, et al.. (2015). The effects of graded levels of calorie restriction: II. Impact of short term calorie and protein restriction on circulating hormone levels, glucose homeostasis and oxidative stress in male C57BL/6 mice. Oncotarget. 6(27). 23213–23237. 77 indexed citations

18.

Mitchell, Sharon E., Zhanhui Tang, Davina Derous, et al.. (2015). The effects of graded levels of calorie restriction: I. impact of short term calorie and protein restriction on body composition in the C57BL/6 mouse. Oncotarget. 6(18). 15902–15930. 84 indexed citations

19.

Porter, John B., Mohsen Saleh Elalfy, Vip Viprakasit, et al.. (2015). Utility of labile plasma iron and transferrin saturation in addition to serum ferritin as iron overload markers in different underlying anemias before and after deferasirox treatment. European Journal Of Haematology. 96(1). 19–26. 26 indexed citations

20.

Gerding, H., Francesco Boscia, Jordi Monés, et al.. (2014). Ranibizumab ±adjunctive laser vs laser in patients with visual impairment due to macular edema secondary to branch retinal vein occlusion (BRVO): Design and baseline characteristics of the BRIGHTER study. 55(13). 607–607. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact